FDA Enforcement Class II Terminated

N Latex CDT Kit

Recall: Z-2931-2018 · Reported September 5, 2018

Enforcement

Recall Number
Z-2931-2018
Event ID
80431
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
CSL Behring GmbH
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
September 5, 2018
Initiation Date
May 31, 2018
Classification Date
August 25, 2018
Termination Date
February 12, 2021
Address
Emil-von-Behring-Str. 76, N/A, Marburg, N/A, N/A, Germany

Description

N Latex CDT Kit

Reason

Siemens Healthcare Diagnostics has observed a negative bias for the carbohydrate-deficient transferrin (CDT) measurement when using the affected N Latex CDT lots in comparison to the HPLC method. CDT results in absolute concentrations may be influenced by patients transferrin levels and, therefore, results are reported as ratio of CDT to total transferrin, called %CDT. As the transferrin determination with N Antiserum to Human Transferrin is not affected, the observed effect leads to calculated %CDT values that show a negative bias of approximately 15% compared to the HPLC method. This could result in a shift of weak positive patient samples into the reference range of 1.19  2.47 %CDT which was derived from a study population of healthy adults. There are no control or calibrator materials that would catch this bias.

Code Info

UDI - 842768018534 Lot # 47169, Exp Date: 2018-06-15 Lot # 47596, Exp Date: 2018-11-30 Lot # 47716, Exp Date: 2018-11-30 Lot # 48084, Exp Date: 2019-03-21 Lot # 48168, Exp Date: 2019-03-21

Distribution

Domestic - DE, IN, KS, MO & VA Internationally - Australia Austria Belgium Canada China Czech Republic Finland France Germany Hungary India Italy Japan Latvia Lithuania Netherlands Norway Poland Portugal Saudi Arabia Slovakia Slovenia South Africa South Koria Spain Sweden Switzerland Taiwan Turkey United Kingdom Uruguay

Quantity

6635 units